Eric Swayze has sold IONS and made no open-market buys since Jan 2023

Eric E. Swayze, Ph.D., is a corporate insider and Executive Vice President, Research at Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), where he leads preclinical antisense drug discovery and antisense technology research.( He has served as Executive Vice President, Research since 2020 and is a long‑tenured scientific leader at Ionis, having joined the company in 1994 and holding prior roles including Vice President of Chemistry and Neuroscience Drug Discovery.( As a corporate officer and principal at Ionis, Swayze has actively participated in insider trading activity in the company’s shares and holds a significant personal stake in Ionis stock.(

Swayze’s career has focused on medicinal chemistry and the mechanisms of RNA‑targeting modalities to treat human diseases, with notable contributions to antisense‑based therapeutic strategies, including the development of Ionis’ Generation 2.5 chemistry and ligand‑conjugated antisense (LICA) technology.( He earned his B.S., M.S., and Ph.D. degrees in Chemistry from the University of Michigan, completing his doctorate in 1994.( This combination of deep academic training in chemistry and three decades of R&D leadership at Ionis has positioned him as a key figure in the company’s scientific innovation and pipeline advancement.(

Written by Perplexity from public sources.